Literature DB >> 13366673

Mecamylamine in treatment of hypertensive disease; observations on an unusual neuromuscular complication.

A C CORCORAN, H P DUSTAN, I H PAGE, R E SCHNECKLOTH.   

Abstract

Entities:  

Keywords:  AUTONOMIC DRUGS/therapeutic use; HYPERTENSION/therapy; MUSCLES/diseases; NERVOUS SYSTEM/effect of drugs on

Mesh：

Substances：

Year:  1956        PMID： 13366673     DOI： 10.1001/jama.1956.02970260018006

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  9 in total

1.  Treatment of hypertension with pentolinium and mecamylamine.

Authors:  H T SEARS; P J SNOW; I B HOUSTON
Journal:  Br Med J       Date:  1959-02-21

2.  Results of treatment in malignant hypertension: a seven-year experience in 94 cases.

Authors:  M HARINGTON; P KINCAID-SMITH; J McMICHAEL
Journal:  Br Med J       Date:  1959-11-14

3.  A clinical evaluation of antihypertensive drugs.

Authors:  I H PAGE
Journal:  Bull N Y Acad Med       Date:  1957-04

4.  Pempidine for Hypertension.

Authors:  K Somers
Journal:  Br Med J       Date:  1961-01-07

5.  The pharmacological actions of pempidine and its ethyl homologue.

Authors:  A SPINKS; E H YOUNG; J A FARRINGTON; D DUNLOP
Journal:  Br J Pharmacol Chemother       Date:  1958-12

6.  Region-specific effects of N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide on nicotine-induced increase in extracellular dopamine in vivo.

Authors:  S Rahman; Z Zhang; R L Papke; P A Crooks; L P Dwoskin; M T Bardo
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

7.  DEPRESSION OF THE VASOMOTOR CENTRE BY MECAMYLAMINE, INDEPENDENT OF ITS GANGLION-BLOCKING ACTIVITY.

Authors:  K P BHARGAVA; K N DHAWAN
Journal:  Br J Pharmacol Chemother       Date:  1963-08

8.  Ion-Selective Carbon Nanotube Field-Effect Transistors for Monitoring Drug Effects on Nicotinic Acetylcholine Receptor Activation in Live Cells.

Authors:  Youngtak Cho; Viet Anh Pham Ba; Jin-Young Jeong; Yoonji Choi; Seunghun Hong
Journal:  Sensors (Basel)       Date:  2020-06-30       Impact factor: 3.576

9.  Mecamylamine inhibits seizure-like activity in CA1-CA3 hippocampus through antagonism to nicotinic receptors.

Authors:  Olha Zapukhliak; Olga Netsyk; Artur Romanov; Oleksandr Maximyuk; Murat Oz; Gregory L Holmes; Oleg Krishtal; Dmytro Isaev
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.